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Abstract
Background and Objective: The prevalence of obesity among school-aged children has increased. Obesity is commonly associated with
an increased risk of cardiovascular disease as it increases secretion of inflammatory markers. Vitamin C has been shown to reduce
inflammation. The current study examined the effect of vitamin C supplementation on high sensitivity-C reactive protein (hsCRP) and
soluble intercellular adhesion molecules-1 (sICAM-1) levels in school-aged, Indonesian children. Materials and Methods: Twenty eight
obese children aged 6-12 years old participated in our quasi-experimental study conducted in 2013. Subjects were classified into two
groups: Intervention (300 mg dayG1 vitamin C for 6 weeks) and control (50 mg dayG1 vitamin C for 6 weeks). The hsCRP and sICAM-1 levels
were measured in both groups before and after each individual supplementation. Results: The Mean±Standard Deviation baseline hsCRP
level at baseline in the intervention and control groups was 1.77±1.24  and 3.84±4.00 mg LG1, respectively (p>0.05). After 6 weeks, the
mean hsCRP level in the intervention and control groups was 3.00±4.73  and 2.94±4.00 mg LG1, respectively (p>0.05). There were no
significant differences in hsCRP level within each group before and after treatment. Conclusion: The HsCRP levels in obese children
included in the present study were higher than accepted normal values (<1.04 mg LG1). Supplementation with vitamin C (300 mg dayG1
total) for 6 weeks did not effectively reduce hsCRP levels among obese school-aged children. Further study is needed to determine a safe
and effective dosage regimen of vitamin C for obese children at greater risk for cardiovascular complications.
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INTRODUCTION
The prevalence of obesity among children in Indonesia is
increasing1. A 2013 national survey reported that 8.8% of
school-aged  children were obese2. Obese children have a
high risk of hypertension, diabetes mellitus type 2, metabolic
and mental disorders3-5. The risk of cardiovascular problems
among obese children is associated with the occurrence of
inflammation  and  endothelial dysfunction6.  Inflammation
influences metabolic control, which negatively affects insulin
sensitivity and glucose transport7. Thus, someone who is
obese with increased levels of inflammatory markers may have
physiological adaptations that negatively affect metabolic and
cardiovascular health8.
Previous studies among adult populations have shown an
association between increased inflammatory marker levels
and  cardiovascular disorders9. For example, increased levels
of  Tumor  Necrosis  Factor-" (TNF-"), interleukin-6 (IL-6) and
C Reactive Protein (CRP) have been shown to induce
cardiovascular disease in both men and women and are also
indicators of type 2 diabetes and metabolic disease10. Waist
circumference and Body Mass Index (BMI) are also found to be
strongly associated with elevated levels of TNF-", IL-6 and CRP
in both adults and children11. Increases in markers of
inflammation are highest in obese children compared to
children of normal weight11,12.
Supplementation with antioxidants is a potential
approach to reducing the risk of cardiovascular problems
caused by inflammation. Vitamin C is an antioxidant that can
stabilize free radicals and inhibit the chain reaction of free
radical formation which can cause oxidative stress13. Previous
studies among adults populations have shown that certain
antioxidants can decrease inflammatory marker levels and
improve endothelial function14,15. However,  study  on  the
effect of vitamin C supplementation on inflammation in obese
children is limited. The current study aims to identify the levels
of the inflammatory marker high sensitivity-CRP (hsCRP) as
well as to determine the effect of vitamin C supplementation
on the levels of high sensitivity-C reactive protein (hsCRP). The
concentration of soluble intercellular adhesion molecules-1
(sICAM-1) was  also  measured  to  examine  endothelial
dysfunction among obese children.
MATERIALS AND METHODS
Study  design  and participants: The  current  study  had  a
pre and post-test quasi-experimental design. Participants
included  obese  children  aged  6-12 years old from Makassar,
Indonesia, with Body Mass Index (BMI) for age z-scores >2
Standard  Deviation  (SD)  according  to  World  Health
Organization (WHO) growth standards16. Sixty obese children
were  identified   after   a   preliminary  screening  of  five
elementary schools; 30 were eligible and willing to participate.
Children on a medication/treatment program and/or suffering
from chronic disease during the study period were excluded.
Participants were randomly divided into two groups:
Intervention  (n = 15)  and  control  (n = 15). However,  two
participants in the intervention group were eventually
excluded because they did not follow the study protocol
completely.  Therefore,   the   intervention   group   included
13 children.
Study protocol: Ethical approval was obtained from the
institutional ethical committee at Hasanuddin University
(Makassar,  Indonesia)  prior  to  study  onset. A written
consent  to  permit  the   children   to   participate   in  the
study was obtained from the parents. Participant body weight
was measured by using a digital scale (Seca) and their
standing height was measured by using Microtoise (Seca). The
BMI for age z-scores were  calculated  using  WHO  AnthroPlus 
version  1.0.3 software17. All anthropometric measurements
were performed by the investigator and a well-trained
nutritionist.
The intervention group was given 100 mg of vitamin C
tablet three times a day (300 mg dayG1 total) for 6 weeks18,
while control participants were given a lower dose of vitamin
C tablet (50 mg dayG1 in one dose) for 6 weeks19. Measurement
of hsCRP and sICAM-1 levels in each group was conducted
before and after supplementation. Blood sample collection
and laboratory  analyses  were  performed  by  Prodia  Clinical
Laboratory, Makassar.
Data analysis: An independent t-test was used to compare
anthropometric parameters as well as hsCRP and sICAM-1
levels,   between    intervention    and    control   groups.
Anthropometric parameters, hsCRP and sICAM-1 levels within
each group were compared using a paired t-test. A p<0.05
was considered statistically significant.
RESULTS
The current study included a total of 28 obese children
(16 males  and  12  females)  aged 6-12 years old
(Mean±Standard Deviation, 10.2±0.8 years), which were
divided  into  two  groups:  Intervention (n = 13) and control
(n = 15)  groups.  The  mean   systolic   blood   pressure   for  all
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participants at baseline was 111.3 mmHg, while mean hsCRP
and sICAM-1 levels were 2.88 mg LG1 and 275.30 ng mLG1,
respectively (Table 1). Although mean hsCRP and sICAM-1
levels in the control group were slightly higher and lower,
respectively,  than  in  the  intervention. No significant
differences   between  these   groups   were   found  at
baseline  (Table  1).    Intergroup   differences  after
supplementation are shown in Table 2; neither hsCRP or
sICAM-1 levels were significantly different between the groups 
(p = 0.96 and 0.06, respectively). The intervention group
showed significant increases  in  body  weight  and body fat
percentage before and after supplementation (Table 3).
However,   hsCRP  levels  were  not  significantly changed
(after 3.002  mg  LG1  and  baseline   1.766   mg   LG1)   as  well
as sICAM-1   levels   (after   300.15   mg   LG1   and  baseline
295.79 mg LG1). The control  group  showed  no  significant 
difference  in  hsCRP or  sICAM-1  levels  before   and   after  
supplementation (Table 4).
Table 1:  Demographic, anthropometric and clinical variables at baseline
Variables Intervention group (n = 13) Mean±SD Control group (n = 15) Mean±SD Total (n = 28)
*Gender
Male 7 (25.0%) 6 (21.4%) 9 (32.1%)
Female 6 (21.4%) 16 (57.1%) 12 (42.9%)
Age (years old) 10.20±0.90 10.20±0.80 10.20±0.8 (9-12)
Body weight (kg) 50.30±11.6 49.30±8.00 49.80±9.6 (33.7-77.8)
BMI (kg mG2) 25.60±3.60 24.90±2.20 25.20±2.9 (19.9-34.1)
BMI for age z-score (BAZ) 2.66±0.47 2.50±0.25 2.57±0.37 (2.0-3.4)
Body fat (%) 35.60±2.00 35.50±2.20 35.60±2.0 (32-40)
Systolic blood pressure (mmHg) 111.60±11.3 110.00±7.10 111.30±9.1 (90-130)
Diastolic blood pressure (mmHg) 75.70±4.90 74 .00±5.00 74.80±4.9 (70-80)
hs-CRP level (mg LG1) 1.77±1.24 3.84±4.00 2.88±3.18 (0.15-12.48)
sICAM-1 level (ng mLG1) 300.15±90.58 253.76±89.96 275.30±85.92 (107.2-26.54)
*Frequency is used, n (%). No significant differences were found between the intervention and control groups by independent t-test
Table 2:  Comparison of anthropometric and clinical parameters between intervention and control group after 6 weeks supplementation
Variables Intervention group (n = 13) Mean±SD Control group (n = 15) Mean±SD *p-value
Body weight (kg) 51.28±11.5 50.73±8.40 0.88
BMI (kg mG2) 25.40±3.50 25.10±2.30 0.78
BMI for age z-score (BAZ) 2.54±0.45 2.47±0.32 0.64
Body fat (%) 36.00±1.80 35.40±2.20 0.45
Systolic blood pressure (mmHg) 102.30±5.90 106.00±7.30 0.16
Diastolic blood pressure (mmHg) 73.00±7.50 74.60±6.30 0.55
hs-CRP level (mg LG1) 3.00±4.73 2.94±4.00 0.96
sICAM-1 level (ng mLG1) 295.79±90.58 234.44±1.67 0.06
*Probability using independent t-test
Table 3:  Change in anthropometric and clinical parameters within the intervention group before and after supplementation
Variables Before supplementation (n = 13) Mean±SD After supplementation (n = 13) Mean±SD *p-value
Body weight (kg) 50.37±11.61 51.28±11.5 0.042
BMI (kg mG2) 25.61±3.64 25.43±3.54 0.451
BMI for age z-score (BAZ) 2.66±0.47 2.54±0.45 0.077
Body fat (%) 35.60±2.00 36.00±1.80 0.040
Systolic blood pressure (mmHg) 111.60±11.3 102.30±5.90 0.012
Diastolic blood pressure (mmHg) 75.70±4.90 73.07±7.50 0.357
hs-CRP level (mg LG1) 1.766±1.25 3.002±4.73 0.322
sICAM-1 level (ng mLG1) 300.15±76.94 295.79±90.58 0.740
*Probability using paired t-test
Table 4:  Change in anthropometric and clinical parameters in control group before and after supplementation
Variables Before supplementation (n = 15) Mean±SD After supplementation (n = 15) Mean±SD *p-value
Body weight (kg) 49.38±8.06 50.73±8.46 0.028
BMI (kg mG2) 24.93±0.56 25.11±2.31 0.547
BMI for age z-score (BAZ) 2.50±0.25 2.47±0.32 0.603
Body fat (%) 35.50±2.20 35.40±2.20 0.546
Systolic blood pressure (mmHg) 111.00±7.10 106.00±7.30 0.140
Diastolic blood pressure (mmHg) 74.00±5.00 74.60±6.30 0.719
hs-CRP level (mg LG1) 3.841±4.00 2.938±1.67 0.257
sICAM-1 level (ng mLG1) 253.76±89.96 234.44±73.76 0.052
*Probability using paired t-test
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DISCUSSION
The present study found the mean systolic blood pressure
of obese school-aged children to be high, similar to previous
reports20,21. The mean hsCRP levels in obese children included
in the  present  study  were  also  found  to  be  higher  than
the normal (accepted) value (<1.04 mg LG1) for children aged
4-18 years old22. Previous studies have shown that increased
hsCRP levels in adult patients with cardiovascular disease
versus healthy subjects can predict acute coronary events23,24.
Although, serum hsCRP levels are an indicator of coronary
heart disease risk particularly in obese children, it is unclear
whether heightened levels are predictive of cardiovascular
disease as the child ages.
Interestingly,  baseline  sICAM-1  levels  were in the
normal range (206.8-486.8 ng mLG1) for all participants
regardless  of  group25.  In  contrast,  a  previous  study of
adolescent populations showed that mean sICAM-1 levels
among obese teens to be higher than those of non-obese
teens26. Although, the present study found sICAM-1 levels in
obese, school-aged children to be in the normal range, it is
possible their levels will increase as they transition into
adolescence or older.
The  present   study   showed   that   vitamin  C
supplementation was not effective in modifying hsCRP levels
in obese children. Conversely, several previous studies
reported that vitamin C supplementation reduced heightened
hsCRP levels in obese and non-obese adults27,28. This disparity
is most  likely  due  to differences in age, dosage and/or
duration of treatment as adults were given higher doses of
vitamin C in each of these studies for longer periods of time.
For example,  Block  et  al.27  administered  1000  mg dayG1 for
2  months,   while   Ellulu   et  al.28  used  500 mg twice a day
(1000  mg dayG1 total) for 8 weeks. Meanwhile, this study used
a total of  300 mg dayG1 for only 6 weeks. We chose to use this
lower dosage to decrease the risk of adverse effects caused by
longer treatment and higher dosages of vitamin C in
children29.
The  effect  of supplementation with high doses of
vitamin C in children is not well documented. Although one
study reported that supplementation with 500 mg of vitamin
C twice daily for 8 weeks in older children (14-18 years old)
showed a positive outcome and decreased sICAM-1 levels26,
the safety and efficacy of this dosage in younger children
remains unclear. Moreover, one previous study of vitamin C
intake among adults showed that >1000 mg daily is
associated with a higher risk of kidney stones30, administration
and dose in children should be carefully implemented.
Therefore, further study to determine the safety and efficacy
of higher doses able to decrease hsCRP levels among obese
children is needed.
The current study has several limitations. First, this study
is lack of random assignment and no non-obese control group
and the number of subjects included in each group is
relatively  small.  Second, we did not take into account the
total daily intake of vitamin C from other sources for each
participant. Nonetheless, the current study provides initial
evidence that low doses of vitamin C for shorter time periods
are less effective at decreasing hsCRP levels in obese children
aged 6-12 years old.
CONCLUSION AND FUTURE RECOMMENDATIONS
The present study found that sICAM-1 levels in obese,
school-aged children are in the normal (accepted) range,
while hsCRP levels were found to be high. Supplementation
with 100 mg of vitamin C thrice daily did not effectively reduce
hsCRP levels in obese children aged 6-12 years old. Therefore,
further study with higher doses of vitamin C and/or long
administration periods is recommended. Future studies
should consider the total intake of vitamin C, involve a larger
sample size and apply a randomized control study.
SIGNIFICANCE STATEMENTS
Obesity  is  associated   with   a   higher  risk  of
cardiovascular disease  by  increasing inflammation and
inflammatory markers, such as hsCRP. Vitamin C is an
antioxidant that has been shown to reduce the risk of
cardiovascular issues by reducing inflammation in adults.
However,   little  is  known  about  the  effect  of   vitamin   C
supplementation   on     the  levels of inflammation   in   obese, 
 school-aged   children.  Thus, determining the occurrence of
inflammation and identifying an appropriate treatment to
reduce the inflammation marker among obese children are
emerging requirement of all stakeholders to set an
appropriate policy.
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